MAZE Competitors & Alternatives
Compare Maze Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
MAZE
Main Stock$26.43
Tradestie Score
37
Market Cap
$1.13B
Analyst Upside
+132.7%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VCEL
Vericel Corporation
|
$40.15
|
$1.56B | 83.9 | 57 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$88.21
|
$1.55B | - | 63 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$39.64
|
$1.55B | 12.7 | 60 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$31.19
|
$1.55B | - | 54 | Compare |
|
NVAX
Novavax Inc
|
$10.46
|
$1.54B | - | 41 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$15.83
|
$1.50B | 7.0 | 49 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$27.67
|
$1.50B | - | 40 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$27.79
|
$1.49B | - | 54 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$24.44
|
$1.43B | - | 66 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$16.93
|
$1.42B | - | 73 | Compare |
More MAZE Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2836)
227 stocks in this industry